Previous Article | Next Article 
Journal of Bacteriology, August 1999, p. 4485-4492, Vol. 181, No. 15
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Autogenous Regulation of the Bacillus
anthracis pag Operon
Alex R.
Hoffmaster and
Theresa M.
Koehler*
Department of Microbiology and Molecular
Genetics, The University of Texas
Houston Health Science Center
Medical School, Houston, Texas 77030
Received 7 April 1999/Accepted 27 May 1999
 |
ABSTRACT |
Protective antigen (PA) is an important component of the edema and
lethal toxins produced by Bacillus anthracis. PA is
essential for binding the toxins to the target cell receptor and for
facilitating translocation of the enzymatic toxin components, edema
factor and lethal factor, across the target cell membrane. The
structural gene for PA, pagA (previously known as
pag), is located on the 182-kb virulence plasmid pXO1 at a
locus distinct from the edema factor and lethal factor genes. Here we
show that a 300-bp gene located downstream of pagA is
cotranscribed with pagA and represses expression of the
operon. We have designated this gene pagR (for protective
antigen repressor). Two pagA mRNA transcripts were detected
in cells producing PA: a short, 2.7-kb transcript corresponding to the
pagA gene, and a longer, 4.2-kb transcript representing a
bicistronic message derived from pagA and pagR.
The 3' end of the short transcript mapped adjacent to an inverted
repeat sequence, suggesting that the sequence can act as a
transcription terminator. Attenuation of termination at this site
results in transcription of pagR. A pagR mutant
exhibited increased steady-state levels of pagA mRNA,
indicating that pagR negatively controls expression of the
operon. Autogenous control of the operon may involve atxA, a trans-acting positive regulator of pagA. The
steady-state level of atxA mRNA was also increased in the
pagR mutant. The mutant phenotype was complemented by
addition of pagR in trans on a multicopy plasmid.
 |
INTRODUCTION |
Bacillus anthracis is the
etiological agent of anthrax, a disease that affects all mammals,
including humans. Key virulence factors of the bacterium include the
proteins that comprise the edema and lethal toxins. These binary toxins
are composed of distinct enzymatic proteins and a common protein that
mediates entry into target cells. Protective antigen (PA) and edema
factor (EF) comprise edema toxin, while PA plus lethal factor (LF)
comprise lethal toxin. PA binds to a specific receptor on target cells
and following endocytosis of the toxin-receptor complex, facilitates
translocation of EF and LF across the cell membrane such that the
enzymatic proteins can contact their cytosolic substrates (15, 19,
34).
The genes encoding the toxin proteins, pagA (previously
known as pag) (which encodes PA), cya (which
encodes EF), and lef (which encodes LF), are located
noncontiguously within a 30-kb region of the 182-kb plasmid, pXO1
(12, 17, 22, 23, 29, 32). As might be expected due to the
pivotal role of PA in intoxication, the pagA gene is highly
expressed. When B. anthracis is cultured under optimal
conditions, culture supernatants contain up to 20 mg of PA per liter,
while LF and EF are present at 5 and 1 mg per liter, respectively
(16). Analyses of toxin gene expression employing reporter
gene fusions suggest that the steady-state level of mRNA of
pagA is 4-fold higher than that of lef and
14-fold higher than that of cya (25).
Two host-related cues, CO2-bicarbonate and temperature, are
important signals for expression of all three toxin genes. During in
vitro growth, optimal expression of pagA, cya,
and lef is achieved when B. anthracis is cultured
in buffered R medium, a defined medium containing glucose, salts, and
all amino acids, or CA medium, a medium containing Casamino Acids and
glucose (16, 21, 27). Toxin synthesis is greatest when
cultures are incubated in elevated (5% or greater) atmospheric
CO2 or when bicarbonate is added to culture medium in a
closed vessel. Toxin synthesis is also increased when cultures are
incubated at 37°C compared to when they are incubated at 28°C.
CO2-bicarbonate- and temperature-controlled gene expression
is at the level of transcription (2, 4, 12, 25, 31).
The atxA gene, located within the toxin gene region of pXO1,
positively controls transcription of all three toxin genes and at least
one gene required for capsule synthesis, capB, which is
located on the 93-kb plasmid pXO2 (9, 12, 29, 30). Under all
growth conditions tested, atxA is essential for
transcription from the unique start sites of cya and
lef and for transcription from the major start site, P1, of
the pagA gene (7, 12). The mechanism by which
atxA activates expression of virulence genes and the
relationship(s) between host-related cues and atxA function
are not known.
In an effort to identify regulatory genes that act downstream of
atxA to activate toxin gene expression, we screened for
CO2-enhanced atxA-dependent loci on pXO1. We
created random transcriptional lacZ fusions using transposon
Tn917-pLTV3 and tested insertion mutants for
CO2-enhanced atxA-dependent
-galactosidase
activity. In addition to mutants harboring transposon insertions in the toxin genes, our screen yielded a number of mutants harboring apparent
CO2-enhanced atxA-regulated fusions at distinct
loci on pXO1 (10). Here we characterize a 300-bp open
reading frame (ORF), pagR, identified in our screen. We show
that the pagR gene is cotranscribed with the toxin gene
pagA and that a pagR mutant shows increased
levels of pagA and atxA transcripts.
 |
MATERIALS AND METHODS |
Strains, media, and growth conditions.
Escherichia
coli JM109 was used as a host for cloning. B. anthracis
strains and their relevant characteristics are listed in Table
1. All B. anthracis strains
are derivatives of the Weybridge strain, a noncapsulated toxigenic
isolate originally obtained from the Microbiological Research
Establishment, Porton Down, England. For DNA extractions, the B. anthracis strains were grown in brain heart infusion medium
(Difco, Detroit, Mich.) containing 10% horse serum. For
electroporation experiments, B. anthracis strains were grown
in brain heart infusion medium containing 0.5% glycerol. For RNA
extractions, B. anthracis strains were grown in CA broth
(27) buffered with 100 mM HEPES (pH 8.0). CA medium contained 0.8% sodium bicarbonate for cultures incubated in 5% CO2.
All antibiotics were purchased from Sigma (St. Louis, Mo.) or Fisher
Scientific (Pittsburgh, Pa.) and were added to media
at the following
concentrations when appropriate: for
E. coli,
ampicillin,
100 µg/ml; kanamycin, 20 µg/ml, and tetracycline,
10 µg/ml; for
B. anthracis, erythromycin, 1 µg/ml; lincomycin,
25 µg/ml; kanamycin, 50 µg/ml; and tetracycline, 5 µg/ml.
Plasmid and strain constructions.
Plasmid DNA was extracted
from B. anthracis by the method of Green et al.
(8). Preparation of plasmid DNA from E. coli, transformation of E. coli, and recombinant DNA techniques
were carried out by standard procedures (1). B. anthracis was electroporated with plasmid DNA from E. coli GM1684, as described previously (12). Restriction
enzymes, T4 ligase, and Taq polymerase were purchased from
Promega (Madison, Wis.) or New England Biolabs (Beverly, Mass.).
Plasmids and their relevant characteristics are shown in Table
1.
Plasmid pUTE308 contains DNA downstream of
pagA, including
the 5' end of
pagR. To construct pUTE308, a 946-bp PCR
product
was generated by using oligonucleotides
5'-GTAAGAAATACAAGGAGAGTATG-3'
and
5'-CGCATAGGA
GGTACCATTGTTTTT-3'. The former
oligonucleotide
is complementary to a region 62 to 85 bp downstream of
the translational
stop of
pagA and just upstream of a
BamHI site (see Fig.
1). The
latter oligonucleotide is
complementary to a region 62 to 86 bp
downstream of the predicted
translational start of
pagR and contains
an engineered
KpnI site (shown in boldface type). The PCR product
was
digested with
BamHI and
KpnI and ligated into
BamHI-
KpnI-digested
pSL301.
Plasmid pUTE331 contains DNA from the 3' end of
pagA through
the 5' end of
pagR. To construct pUTE331, a 1.1-kb PCR
product
was generated with oligonucleotides
5'-GGGGATACTTAGTACCAACGGG-3'
and
5'-GTTCAGCATCATCTTCTAAACTC-3'. The former oligonucleotide
is
complementary to a region 45 to 68 bp upstream of the translational
stop codon of
pagA. The latter oligonucleotide is
complementary
to a region 36 to 58 bp downstream of the predicted
translational
start of
pagR. The PCR product was ligated
into pGEM-T.
Plasmid pUTE334 carries
pagA and
pagR. It was
created by first ligating a
BamHI-
SacI fragment
(containing
pagR) from pUTE103
into
BamHI-
SacI-digested pUTE41 (containing
pagA), resulting in
pUTE333. The 5.6-kb
SacI-
KpnI fragment from pUTE333 was ligated
into
SacI-
KpnI-digested pUTE29, resulting in pUTE334.
The frameshift
mutation within
pagR (pUTE366) was generated
by using the Transformer
Site-Directed Mutagenesis kit from Clontech
(Palo Alto, Calif.).
The oligonucleotide,
5'-GACAGTATTTGTA
CGATCATAAAATTG-3', was used
as a
mutagenic primer to add a C residue (underlined) 15 bases
downstream of
the ATG start codon of
pagR. The frameshift mutation
was
confirmed by DNA
sequencing.
UT119 carries the
km-2 element inserted in the
BamHI site between
pagA and
pagR (see
Fig.
1). Insertion of the
km-2 element
into the
B. anthracis genome was accomplished as described previously
(
7). To create UT119, pUTE315 (Table
1) was electroporated
into UM44 with selection for kanamycin resistance. UT119 was isolated
following a screen for tetracycline-sensitive
kanamycin-resistant
mutants. The location of the
km-2 element was confirmed by using
PCR.
RNA analysis.
Methods for RNA extraction, primer extension
reactions, and RNase T2 protection assays have been described (12,
28). RNA was extracted from B. anthracis cultures
grown to late log phase (optical density at 600 nm of 0.8 to 1.0) in CA
medium. RNA was quantified spectrophotometrically and by visualization
on 1.2% formaldehyde gels. Oligonucleotides used for atxA
and pagA primer extensions were described previously
(6). Oligonucleotides were labeled with
[
-32P]ATP (6,000 Ci/mmol) (Amersham Corp., Arlington
Heights, Ill.), hybridized to 20 µg of RNA, and extended by using
avian myeloblastosis virus reverse transcriptase (Promega). The 5' ends
of the atxA and pagA genes were sequenced by the
dideoxy-chain termination method (1), using the appropriate
primers and a Sequenase version 2.0 DNA sequencing kit purchased from
United States Biochemical Corp. (Cleveland, Ohio). The
[
-35S]dATP (>1,000 Ci/mmol) for sequencing was
purchased from Amersham Corp. Primer extension and sequencing reaction
mixtures were subjected to electrophoresis on 6% polyacrylamide and
42% urea gels. Primer extension products were quantified by using a
Packard Instant Imager.
Antisense RNA probes (riboprobes) 1 and 2 (for illustrations see Fig.
3A) were used for RNase T2 protection assays. RNA polymerases
and RNase
T2 were purchased from Promega. To make riboprobe 1,
pUTE331 was
linearized with
NcoI and antisense RNA was generated
by
using Sp6 RNA polymerase and [

-
32P]CTP (>800 Ci/mmol)
(Amersham). To make riboprobe 2, pUTE308
was linearized with
BamHI and antisense RNA was generated by using
T7 RNA
polymerase and [

-
32P]CTP. Riboprobes were hybridized
to 20 µg of
B. anthracis RNA
prior to digestion with RNase
T2.
For Northern hybridizations, biotinylated DNA probes complementary to
the internal DNA sequences of
pagA and
pagR were
created
by using a Phototope kit (New England Biolabs). A 1.7-kb
XmnI-
HincII
fragment from pUTE40 was biotinylated
to make the
pagA probe.
The
pagR probe was made
from a 242-bp PCR product generated by
the following oligonucleotides:
5'-GAGTTTAGAAGATGATGCTGAAC-3'
and
5'-TAATAATCCCTTCAACTTTTGG-3'. The oligonucleotide primers
were complementary to regions 35 to 58 and 264 to 286 bp downstream
of
the predicted translational start codon of
pagR. Twenty
micrograms
of RNA was run on a 1.2% agarose gel (containing
formaldehyde)
and capillary blotted to Maximum Strength Nytran Plus
membranes
(Schleicher & Schuell, Keene, N.H.). Membranes were
hybridized
with probes overnight at 45°C. Blots were developed by
using a
Phototope-Star detection kit (New England Biolabs) and exposed
to
film.
Immunoblotting.
Relative levels of PA produced by parent and
mutant strains were determined by assaying cell lysates for protein
that reacted with polyclonal anti-PA antiserum. PA in culture
supernatants is subject to varying levels of degradation by proteases
secreted by B. anthracis. Therefore, for monitoring small
differences in PA levels, more-reproducible data can be obtained by
examining cell lysates rather than culture supernatants. B. anthracis cultures were grown in 25 ml of CA medium to an optical
density at 600 nm of 0.8 to 1.0. Cells were collected on cellulose
acetate membranes (pore size, 0.45 µm) (Nalge, Rochester, N.Y.),
resuspended in 1 ml of buffer (1% sodium dodecyl sulfate, 200 mM
dithiothreitol, 28 mM Tris HCl, 22 mM Tris OH, 2 mM
phenylmethylsulfonyl fluoride), and passed through a French press
minicell three times at 20,000 lb/in2. The soluble fraction
was obtained following centrifugation at 16,000 × g
for 5 min, and protein concentrations were determined by using a
Bio-Rad protein assay reagent (Bio-Rad, Hercules, Calif.). Samples (5 µg) were subjected to electrophoresis on sodium dodecyl sulfate-7.5% polyacrylamide gels.
Following electrophoresis, proteins were transferred to nitrocellulose
membranes by electroblotting. Membranes were reacted
with rabbit
anti-PA serum (diluted 1:6,000 in TBS-T (20 mM Tris
OH, 137 mM NaCl,
0.1% Tween 20 [pH 7.6]) containing 5% milk for
2 h at room
temperature. Membranes were washed in TBS-T and finally
reacted with
donkey anti-rabbit immunoglobulin G antibody conjugated
to horseradish
peroxidase (1:4,000 in TBS-T with 5% milk) for
1 h at room
temperature. Cross-reactive material was visualized
on autoradiographs
by using an ECL immunodetection kit purchased
from Amersham (Little
Chalfont, Buckinghamshire,
England).
Nucleotide sequence accession number.
The complete
nucleotide sequence of the pagR gene and flanking regions
has been deposited in the GenBank database under accession no.
AF031382.
 |
RESULTS |
Identification of pagR.
In experiments reported
previously, we used the transposon Tn917-pLTV3 to identify
B. anthracis promoters that exhibited increased expression
during growth in elevated CO2 and were
atxA-dependent (10). Tn917-LTV3
carries a promoterless lacZ gene at one end and generates a
transcriptional fusion when inserted downstream of an active promoter
(3). In this investigation, we studied one
Tn917-pLTV3 insertion mutant that showed CO2-
and atxA-dependent
-galactosidase activity.
Restriction analysis and Southern hybridization experiments revealed
that the mutant UT82 contained a Tn
917-pLTV3 insertion
in
the approximately 2.8-kb region between the
pagA and
lef genes
on pXO1 (data not shown). We cloned and sequenced
this intergenic
region from the parent strain. To determine the exact
insertion
site and orientation of Tn
917-pLTV3 in UT82, we
cloned and sequenced
the
B. anthracis DNA flanking the 5'
end of the transposon insertion.
As shown in Fig.
1, sequence analysis indicated that the
transposon
insertion was 1,339 nucleotides (nt) downstream of
pagA. A 300-nt
ORF was noted between
pagA and the
Tn
917-LTV3 insertion. This
ORF lies in the same orientation
as the
pagA gene and the promoterless
lacZ gene
associated with the transposon. The 3' end of the ORF
maps to 122 bp
upstream of the transposon insertion. For reasons
made evident below,
we have designated the downstream ORF
pagR (for protective
antigen repressor). A potential ribosome binding
site beginning 12 bp
upstream of the translational start codon
of
pagR was noted.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 1.
pXO1 DNA sequence extending from the 3' end of
pagA through pagR. Predicted amino acid sequences
are indicated under the pagA and pagR DNA
sequences. Straight arrows indicate an inverted repeat sequence,
located downstream of pagA, that functions as a weak
transcription terminator. A potential ribosome binding site upstream of
pagR is underlined. A tyrosine residue predicted to be a
tyrosine kinase phosphorylation site is boxed. Locations of a
BamHI site (the site of the km-2 insertion in
UT119) and a Tn917-LTV3 insertion in UT82 are as
indicated.
|
|
The
pagR gene is predicted to encode a 99-amino-acid protein
with sequence similarity to two proteins that regulate transcription
in
other species. The predicted
pagR gene product is 26%
identical
and 52% similar to CadC (13.5 kDa), a predicted regulator of
cadmium
resistance in
Listeria monocytogenes
(
14). The putative PagR
protein is 33% identical and 57%
similar to NolR (13.3 kDa), a
trans-acting negative
regulator of the
nod regulon of
Rhizobium meliloti (
13). The NolR protein has been shown to bind
specifically
to promoter regions of several
nod genes. The
sequence similarity
of PagR to both NolR and CadC is found throughout
the predicted
amino acid sequences of the proteins. Analysis of the
PagR amino
acid sequence by using the motifs program from the
University
of Wisconsin Genetics Computer Group (GCG) software package
identified
a potential tyrosine kinase phosphorylation site in the
carboxy-terminal
region of the protein (Fig.
1).
pagR is cotranscribed with pagA.
Northern
hybridization experiments were performed to detect mRNA corresponding
to the pagR gene. Biotinylated DNA probes corresponding to
sequences internal to pagR and pagA were
hybridized to RNA isolated from the parental strain, UM44, and mutants
UT62 and UT119. Results are shown in Fig.
2. Hybridization of the pagR probe with UM44 RNA revealed a single band representing a 4.2-kb transcript, while hybridization of UM44 RNA with the pagA
probe resulted in two bands corresponding to 4.2- and 2.7-kb
transcripts. Mutations in UT62 and UT119 are shown schematically in
Fig. 2C. UT62 carries an
km-2 insertion that prevents
transcription from the major transcription start site of
pagA (12). RNA isolated from UT62 did not
hybridize to the pagR or pagA probes. UT119 is a
mutant containing an
km-2 insertion in a BamHI
restriction site (Fig. 1) between the pagA and
pagR genes. No transcripts were detected when UT119 RNA was
probed with pagR. When the pagA probe was
hybridized to RNA from UT119, only the smaller, 2.7-kb transcript was
detected. Taken together, these results indicate that transcription
from the pagA promoter results in a monocistronic transcript
corresponding to pagA and a bicistronic transcript corresponding to pagA and pagR (see Fig. 2C).

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 2.
Northern blot detection of pagR and
pagA mRNA. RNA samples (20 µg) from cells grown at 37°C
in 5% CO2 were probed with biotinylated DNA probes
corresponding to sequences internal to pagR (A) and
pagA (B). Transcript sizes are indicated. (C) The relative
locations of the pagA and pagR mRNA transcripts
and the km-2 insertions in UT62 and UT119 are shown.
|
|
The size of the monocistronic transcript is indicative of termination
between the
pagA and
pagR genes. Welkos et al.
(
33)
proposed that a nucleotide sequence beginning 43 bp
downstream
of the
pagA coding sequence represents a
transcription terminator
(Fig.
1 and
3A).
The sequence could facilitate formation of a
hairpin structure with a
19-bp stem and a calculated free energy
of

22.2 kcal/mol. We
performed RNase T2 protection assays to
determine if the 3' end of the
short transcript mapped near this
site. A riboprobe extending from the
center of
pagR to 114 bp
upstream of the inverted repeat
sequence (riboprobe 1, Fig.
3A)
was hybridized to RNA from UM44 and
subsequently digested with
RNase T2. Two small, protected fragments
were observed (Fig.
3B,
lane 1). The sizes of the fragments, 162 and
167 nt, indicate
that they are
pagA transcripts with 3' ends
mapping 3 and 8 bp
downstream of the inverted repeat sequence. As
expected, the full-length
probe was also protected from digestion with
RNase T2 due to hybridization
with the bicistronic
(
pagA-pagR) transcript (not shown in the
figure). These
results indicate that termination occurs at the
predicted site but is
incomplete. The inverted repeat sequence
can therefore be considered an
attenuator.

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 3.
Mapping the 3' ends of the monocistronic pagA
transcript and determining the effects of CO2 and
atxA on pagR expression. RNase T2 protection
assays were performed with 20 µg of RNA. (A) Locations of antisense
riboprobes, the km-2 insertion in UT119, and the
transcription attenuator are shown. (B) Lane 1: riboprobe 1 was
hybridized to RNA from UM44 grown in 5% CO2. RNase
T2-protected fragments are indicated. Lanes 2 and 3: nucleotide size
markers, as indicated. (C) Riboprobe 2 was hybridized to RNA from cells
grown in 5% CO2 or in air, as indicated. RNase
T2-protected fragments are shown. Size markers are as indicated. The
probe is 1,167 nt (including 222 nt of vector-derived sequences).
|
|
Transcription of
pagA from the major start site, P1, is
dependent upon the
trans-acting regulatory gene,
atxA (
12). In addition,
steady-state levels of
pagA mRNA are increased when cells are
grown in elevated
levels of CO
2-bicarbonate compared to growth
in air
(
2,
12,
25). RNase T2 protection assays were performed
to
confirm that control of
pagR transcription was similar to
that
of the
pagA gene. A riboprobe extending from within
pagR to a
BamHI restriction site located
between the
pagA and
pagR genes
(riboprobe 2, Fig.
3A) was hybridized to RNA isolated from UM44,
UT53, UT53 (pUTE34),
and UT119 and subsequently digested with
RNase T2. Results are shown in
Fig.
3C. All RNase-protected hybridization
products were of similar
size, indicating complete protection
of the probe, as expected. The
comparison of the intensities of
bands obtained by using RNA from UM44
cultured in 5% CO
2 and RNA
from UM44 cultured in air
confirmed that the
pagR transcript is
CO
2-regulated. No transcript was detected by using RNA
isolated
from the
atxA-null mutant, UT53.
pagR
transcript was detected
in RNA isolated from UT53 carrying
atxA in
trans on pUTE34, although
the amount was
lower than the wild-type level. It has been shown
previously that the
steady-state level of
pagA transcripts in
strains
overexpressing
atxA in
trans is significantly
lower than
that detected in the UM44 parent strain (
6). No
pagR transcript
was detected from UT119, confirming that
there are no
pagR transcripts
that initiate between
pagA and
pagR. Thus,
pagR is
cotranscribed
with
pagA and is expressed in a manner similar
to
pagA.
pagR represses pagA expression.
Considering that pagR is cotranscribed with pagA
and that the predicted PagR protein has sequence similarity to
regulators of transcription, we hypothesized that pagR
affects expression of pagA in a feedback control loop.
Primer extension experiments were performed to measure steady-state
levels of pagA transcripts in UM44 and UT119
(pagR) grown at 37°C in 5% CO2. Results of a representative experiment are shown in Fig.
4A. In repeated experiments, the level of
pagA transcript was 2.5- to 7.0-fold higher in UT119 than in
UM44, indicating that pagR represses pagA
expression. It is not clear why the level of repression varied in
different experiments. Identical RNA samples used to measure expression of atxA (see below) did not exhibit such variation. Western
blottings were performed to determine if the increase in
pagA expression in the pagR mutant also led to an
increase in PA protein level (Fig. 4B). Levels of PAs from UT119
lysates were 2.0-fold higher than those from UM44 lysates.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 4.
Regulation of pagA by pagR.
Cultures for isolation of RNA and protein were incubated in 5%
CO2. Strains are as indicated. (A) Primer extension
experiments were performed with 20 µg of RNA. The end-labeled primer
was complementary to a 33-bp sequence located 32 nt downstream of the
first nucleotide of the pagA translational start site. Lanes
G, A, T, and C correspond to the dideoxy sequencing reaction carried
out with the same oligonucleotide primer. (B) Western blot showing PA
detected in cell lysates.
|
|
pagR represses atxA expression.
The
pagA gene is positively regulated in trans by
atxA (12, 29). We tested for
pagR-controlled expression of atxA. Results of
primer extension experiments are shown in Fig.
5. The steady-state level of
atxA mRNA was increased twofold in UT119 (pagR)
compared to that in UM44, indicating that pagR represses
atxA at a low level.

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 5.
Regulation of atxA by pagR. Primer
extensions were performed as described in the legend for Fig. 4. The
end-labeled primer was complementary to a 27-bp sequence located 55 bp
downstream of the first nucleotide of the translational start site of
the atxA gene. Strains are as indicated.
|
|
UT119 contains an
km-2 insertion between the
pagA and
pagR genes and does not express
pagR. To confirm that the UT119 phenotype
was due to the
lack of
pagR expression, we attempted to complement
UT119
with a plasmid containing
pagR under the control of the
isopropyl-

-
D-thiogalactopyranoside (IPTG)-inducible
promoter
P
spac (
36). After induction with IPTG,
the
pagR transcript in
UT119 containing the recombinant
plasmid was barely detectable,
suggesting that the truncated transcript
was unstable. Therefore,
we tested for complementation of the UT119
phenotype using two
different constructs. Plasmid pUTE334 contains a
5.6-kb pXO1 fragment
containing
pagA and
pagR.
Plasmid pUTE366 contains the same pXO1
fragment with a frameshift
mutation within
pagR. As shown in Fig.
5, pUTE334
complemented the mutation in UT119, restoring
atxA expression to the level observed in the parent strain, UM44. UT119
was
not complemented by pUTE366. These results show that the UT119
phenotype is due to disruption of
pagR expression.
 |
DISCUSSION |
In this study, we determined that a previously unknown gene,
pagR, is cotranscribed with the toxin gene pagA
(previously known as pag) and negatively controls expression
of the operon. Incomplete transcription termination near the 3' end of
an inverted repeat sequence downstream of pagA results in
mono- and bicistronic transcripts containing pagA mRNA.
There is no evidence that attenuation at this site is regulated.
Expression of pagR appears to mimic pagA expression. In light of our results, we refer to the structural gene
for PA as pagA. Thus, the pag operon is composed
of pagA and pagR.
The predicted amino acid sequence of the putative PagR protein is
similar to those of regulatory proteins NolR from R. meliloti (13) and CadC from L. monocytogenes
(14). NolR and CadC contain helix-turn-helix motifs and are
predicted to be DNA-binding proteins. If the PagR protein binds DNA
specifically, the PagR target may be within the promoter region of
pagA or within the promoter region of some other gene that
affects pagA expression.
A pagR mutant shows elevated expression of pagA
and atxA, a trans-acting positive regulator of
pagA. Yet it is unlikely that increased pagA
expression in a pagR mutant is attributed simply to
increased AtxA levels. Results of previous studies indicate that AtxA
levels are not limiting for expression of pagA. Strains carrying multiple copies of the pagA promoter synthesize
normal levels of PA (24). Furthermore, a 10-fold increase in
atxA expression has a negative effect on pagA
expression, resulting in a 60 to 70% decrease in PA levels
(6). Thus, PagR may control expression of the pag
operon independent of AtxA or in conjunction with AtxA and some other
regulatory protein(s).
Our data indicate that pagR functions to limit
pagA expression under culture conditions which are optimal
for synthesis of protective antigen. In experiments not presented here,
we tested virulence of the pagR mutant in a mouse model for
anthrax. Subcutaneous inoculation of mice with high doses of spores of
the toxigenic noncapsulated Sterne strain results in a lethal disease
(20). In this model, the 50% lethal dose for the
pagR mutant was the same as that for the parent strain
(11). This result indicates that increased PA synthesis by
the pagR strain does not increase virulence in the mouse
model. It is also possible that pagR function during
infection differs from that observed during culture of B. anthracis in vitro.
The pagA gene is the only toxin gene that is known to be
transcribed in an operon. The 5' ends of transcripts corresponding to
the cya and lef genes have been mapped
(7); however, the sizes of the cya and
lef transcripts have not been determined. Sequence analysis
of regions downstream of cya and lef does not indicate that there are putative transcription regulators adjacent to
these genes. A 332-bp ORF lies 286 bp downstream of cya and in the same orientation (accession no. AF003936). The predicted protein
product of this ORF has sequence similarity to the purine salvage
pathway enzyme adenine phosphoribosyltransferase of many organisms. A
303-bp ORF is located 1.4-kb downstream of lef and in the
same orientation (accession no. AF031382). The predicted protein
product of this ORF has no homology to any sequences in GenBank.
The pagA gene is coordinately expressed with the other toxin
genes, cya and lef, in response to the same
signals, i.e., CO2-bicarbonate and temperature, and the
same activator, atxA. It is possible that pagR
also regulates the cya and lef genes. Cataldi et
al. (5) examined EF activity and LF protein level in the
culture supernatant of a B. anthracis strain harboring an
erythromycin resistance cassette in the pagA gene. EF
activity was increased twofold, while LF protein level was unchanged,
compared to that in the strain without the cassette (5). If
the insertion in the pagA mutant had a polar effect on
pagR expression, it is possible that the observed increase
in EF activity was due to increased expression of cya in the
absence of pagR expression. In future experiments we will
address the mechanism for pagR-mediated repression and
determine whether or not pagR also regulates the
other toxin genes.
 |
ACKNOWLEDGMENTS |
We thank Jean-Claude Sirard and Michele Mock of the
Institut Pasteur for performing virulence assays. We are grateful to
Malcolm Winkler for helpful discussions and use of equipment and Heidi Kaplan for critical reading of the manuscript.
This work was supported by Public Health Service grant AI33537 from the
National Institutes of Health.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Molecular Genetics, University of Texas
Houston
Health Science Center Medical School, 6431 Fannin St., JFB 1.765, Houston, TX 77030. Phone: (713) 500-5450. Fax: (713) 500-5499. E-mail: tkoehler{at}utmmg.med.uth.tmc.edu.
 |
REFERENCES |
| 1.
|
Ausubel, F. M.,
R. Brent,
R. E. Kingston,
D. D. Moore,
J. G. Seidman,
J. A. Smith, and K. Struhl.
1996.
Current protocols in molecular biology.
John Wiley & Sons, New York, N.Y.
|
| 2.
|
Bartkus, J. M., and S. H. Leppla.
1989.
Transcriptional regulation of the protective antigen gene of Bacillus anthracis.
Infect. Immun.
57:2295-2300[Abstract/Free Full Text].
|
| 3.
|
Camilli, A.,
D. A. Portnoy, and P. Youngman.
1990.
Insertional mutagenesis of Listeria monocytogenes with a novel Tn917 derivative that allows direct cloning of DNA flanking transposon insertions.
J. Bacteriol.
172:3738-3744[Abstract/Free Full Text].
|
| 4.
|
Cataldi, A.,
A. Fouet, and M. Mock.
1992.
Regulation of pag gene expression in Bacillus anthracis: use of a pag-lacZ transcriptional fusion.
FEMS Microbiol. Lett.
98:89-94.
|
| 5.
|
Cataldi, A.,
E. Labruyere, and M. Mock.
1990.
Construction and characterization of a protective antigen-deficient Bacillus anthracis strain.
Mol. Microbiol.
4:1111-1117[Medline].
|
| 6.
|
Dai, Z., and T. M. Koehler.
1997.
Regulation of anthrax toxin activator gene (atxA) expression in Bacillus anthracis: temperature, not CO2/bicarbonate, affects AtxA synthesis.
Infect. Immun.
65:2576-2582[Abstract].
|
| 7.
|
Dai, Z.,
J.-C. Sirard,
M. Mock, and T. M. Koehler.
1995.
The atxA gene product activates transcription of the anthrax toxin genes and is essential for virulence.
Mol. Microbiol.
16:1171-1181[Medline].
|
| 8.
|
Green, B. D.,
L. Battisti,
T. M. Koehler, and C. B. Thorne.
1985.
Demonstration of a capsule plasmid in Bacillus anthracis.
Infect. Immun.
49:291-297[Abstract/Free Full Text].
|
| 9.
|
Guignot, J.,
M. Mock, and A. Fouet.
1997.
AtxA activates the transcription of genes harbored by both Bacillus anthracis virulence plasmids.
FEMS Microbiol. Lett.
147:203-207[Medline].
|
| 10.
|
Hoffmaster, A. R., and T. M. Koehler.
1997.
The anthrax toxin activator gene atxA is associated with CO2-enhanced non-toxin gene expression in Bacillus anthracis.
Infect. Immun.
65:3091-3099[Abstract].
|
| 11.
| Koehler, T. M. Unpublished results.
|
| 12.
|
Koehler, T. M.,
Z. Dai, and M. Kaufman-Yarbray.
1994.
Regulation of the Bacillus anthracis protective antigen gene: CO2 and a trans-acting element activate transcription from one of two promoters.
J. Bacteriol.
176:586-595[Abstract/Free Full Text].
|
| 13.
|
Kondorosi, E.,
M. Pierre,
M. Cren,
U. Haumann,
M. Buire,
B. Hoffmann,
J. Schell, and A. Kondorosi.
1991.
Identification of NolR, a negative transacting factor controlling the nod regulon in Rhizobium meliloti.
J. Mol. Biol.
222:885-896[Medline].
|
| 14.
|
Lebrun, M.,
A. Audurier, and P. Cossart.
1994.
Plasmid-borne cadmium resistance genes in Listeria monocytogenes are similar to cadA and cadC of Staphylococcus aureus and are induced by cadmium.
J. Bacteriol.
176:3040-3048[Abstract/Free Full Text].
|
| 15.
|
Leppla, S. H.
1995.
Anthrax toxins, p. 543-572.
In
J. Moss, B. Iglewski, M. Vaughan, and A. T. Tu (ed.), Bacterial toxins and virulence factors in disease. Marcel Dekker, New York, N.Y.
|
| 16.
|
Leppla, S. H.
1988.
Production and purification of anthrax toxin.
Methods Enzymol.
165:103-116[Medline].
|
| 17.
|
Mock, M.,
E. Labruyere,
P. Glaser,
A. Danchin, and A. Ullmann.
1988.
Cloning and expression of the calmodulin-sensitive Bacillus anthracis adenylate cyclase in Escherichia coli.
Gene
64:277-284[Medline].
|
| 18.
|
Perez-Casal, J.,
M. G. Caparon, and J. R. Scott.
1991.
Mry, a trans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems.
J. Bacteriol.
173:2617-2624[Abstract/Free Full Text].
|
| 19.
|
Petosa, C.,
R. J. Collier,
K. R. Klimpel,
S. H. Leppla, and R. C. Liddington.
1997.
Crystal structure of the anthrax toxin protective antigen.
Nature
385:833-838[Medline].
|
| 20.
|
Pezard, C.,
P. Berche, and M. Mock.
1991.
Contribution of individual toxin components to virulence of Bacillus anthracis.
Infect. Immun.
59:3472-3477[Abstract/Free Full Text].
|
| 21.
|
Ristroph, J. D., and B. E. Ivins.
1983.
Elaboration of Bacillus anthracis antigens in a new, defined culture medium.
Infect. Immun.
39:483-486[Abstract/Free Full Text].
|
| 22.
|
Robertson, D., and S. H. Leppla.
1986.
Molecular cloning and expression in Escherichia coli of the lethal factor gene of Bacillus anthracis.
Gene
44:71-78[Medline].
|
| 23.
|
Robertson, D. L.,
M. T. Tippetts, and S. H. Leppla.
1988.
Nucleotide sequence of the Bacillus anthracis edema factor gene (cya): a calmodulin-dependent adenylate cyclase.
Gene
73:363-371[Medline].
|
| 24.
|
Sirard, J.-C.,
M. Mock, and A. Fouet.
1995.
Molecular tools for the study of transcriptional regulation in Bacillus anthracis.
Res. Microbiol.
146:729-737[Medline].
|
| 25.
|
Sirard, J.-C.,
M. Mock, and A. Fouet.
1994.
The three Bacillus anthracis toxin genes are coordinately regulated by bicarbonate and temperature.
J. Bacteriol.
176:5188-5192[Abstract/Free Full Text].
|
| 26.
|
Thorne, C. B.
1985.
Genetics of Bacillus anthracis, p. 56-62.
In
L. Leive (ed.), Microbiology. American Society for Microbiology, Washington, D.C.
|
| 27.
|
Thorne, C. B., and F. C. Belton.
1957.
An agar-diffusion method for titrating Bacillus anthracis immunizing antigen and its application to a study of antigen production.
J. Gen. Microbiol.
17:505-516[Abstract/Free Full Text].
|
| 28.
|
Tsui, H.-C. T.,
A. J. Pease,
T. M. Koehler, and M. E. Winkler.
1994.
Detection and quantitation of RNA transcribed from bacterial chromosomes and plasmids, p. 179-204.
In
K. W. Adolph (ed.), Molecular microbiology techniques, Part A. Academic Press Inc., San Diego, Calif.
|
| 29.
|
Uchida, I.,
J. M. Hornung,
C. B. Thorne,
K. R. Klimpel, and S. H. Leppla.
1993.
Cloning and characterization of a gene whose product is a trans-activator of anthracis toxin synthesis.
J. Bacteriol.
175:5329-5338[Abstract/Free Full Text].
|
| 30.
|
Uchida, I.,
S.-I. Makino,
T. Sekizaki, and N. Terakado.
1997.
Cross-talk to the genes for Bacillus anthracis capsule synthesis by atxA, the gene encoding the trans-activator of anthrax toxin synthesis.
Mol. Microbiol.
23:1229-1240[Medline].
|
| 31.
|
Vietri, N. J.,
R. Marrero,
T. A. Hoover, and S. L. Welkos.
1995.
Identification and characterization of a trans-activator involved in the regulation of encapsulation by Bacillus anthracis.
Gene
152:1-9[Medline].
|
| 32.
|
Vodkin, M. H., and S. H. Leppla.
1983.
Cloning of the protective antigen gene of Bacillus anthracis.
Cell
34:693-697[Medline].
|
| 33.
|
Welkos, S. L.,
J. R. Lowe,
F. Eden-McCutchan,
M. Vodkin,
S. H. Leppla, and J. J. Schmidt.
1988.
Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis.
Gene
69:287-300[Medline].
|
| 34.
|
Wesche, J.,
J. L. Elliott,
P. O. Falnes,
S. Olsnes, and R. J. Collier.
1998.
Characterization of membrane translocation by anthrax protective antigen.
Biochemistry
37:15737-15746[Medline].
|
| 35.
|
Yanisch-Perron, C.,
J. Vieira, and J. Messing.
1985.
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.
Gene
33:103-119[Medline].
|
| 36.
|
Yansura, D. F., and D. J. Henner.
1984.
Use of the Escherichia coli lac repressor and operator to control gene expression in Bacillus subtilis.
Proc. Natl. Acad. Sci. USA
81:439-443[Abstract/Free Full Text].
|
Journal of Bacteriology, August 1999, p. 4485-4492, Vol. 181, No. 15
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Sastalla, I., Chim, K., Cheung, G. Y. C., Pomerantsev, A. P., Leppla, S. H.
(2009). Codon-Optimized Fluorescent Proteins Designed for Expression in Low-GC Gram-Positive Bacteria. Appl. Environ. Microbiol.
75: 2099-2110
[Abstract]
[Full Text]
-
Hadjifrangiskou, M., Koehler, T. M.
(2008). Intrinsic curvature associated with the coordinately regulated anthrax toxin gene promoters. Microbiology
154: 2501-2512
[Abstract]
[Full Text]
-
Harvill, E. T., Osorio, M., Loving, C. L., Lee, G. M., Kelly, V. K., Merkel, T. J.
(2008). Anamnestic Protective Immunity to Bacillus anthracis Is Antibody Mediated but Independent of Complement and Fc Receptors. Infect. Immun.
76: 2177-2182
[Abstract]
[Full Text]
-
Gueune, H., Durand, M.-J., Thouand, G., DuBow, M. S.
(2008). The ygaVP Genes of Escherichia coli Form a Tributyltin-Inducible Operon. Appl. Environ. Microbiol.
74: 1954-1958
[Abstract]
[Full Text]
-
Heninger, S., Drysdale, M., Lovchik, J., Hutt, J., Lipscomb, M. F., Koehler, T. M., Lyons, C. R.
(2006). Toxin-Deficient Mutants of Bacillus anthracis Are Lethal in a Murine Model for Pulmonary Anthrax. Infect. Immun.
74: 6067-6074
[Abstract]
[Full Text]
-
Chen, Y., Tenover, F. C., Koehler, T. M.
(2004). {beta}-Lactamase Gene Expression in a Penicillin-Resistant Bacillus anthracis Strain. Antimicrob. Agents Chemother.
48: 4873-4877
[Abstract]
[Full Text]
-
Bourgogne, A., Drysdale, M., Hilsenbeck, S. G., Peterson, S. N., Koehler, T. M.
(2003). Global Effects of Virulence Gene Regulators in a Bacillus anthracis Strain with Both Virulence Plasmids. Infect. Immun.
71: 2736-2743
[Abstract]
[Full Text]
-
Berry, C., O'Neil, S., Ben-Dov, E., Jones, A. F., Murphy, L., Quail, M. A., Holden, M. T. G., Harris, D., Zaritsky, A., Parkhill, J.
(2002). Complete Sequence and Organization of pBtoxis, the Toxin-Coding Plasmid of Bacillus thuringiensis subsp. israelensis. Appl. Environ. Microbiol.
68: 5082-5095
[Abstract]
[Full Text]
-
Pannucci, J., Okinaka, R. T., Sabin, R., Kuske, C. R.
(2002). Bacillus anthracis pXO1 Plasmid Sequence Conservation among Closely Related Bacterial Species. J. Bacteriol.
184: 134-141
[Abstract]
[Full Text]
-
Cohen, S., Mendelson, I., Altboum, Z., Kobiler, D., Elhanany, E., Bino, T., Leitner, M., Inbar, I., Rosenberg, H., Gozes, Y., Barak, R., Fisher, M., Kronman, C., Velan, B., Shafferman, A.
(2000). Attenuated Nontoxinogenic and Nonencapsulated Recombinant Bacillus anthracis Spore Vaccines Protect against Anthrax. Infect. Immun.
68: 4549-4558
[Abstract]
[Full Text]
-
Okinaka, R. T., Cloud, K., Hampton, O., Hoffmaster, A. R., Hill, K. K., Keim, P., Koehler, T. M., Lamke, G., Kumano, S., Mahillon, J., Manter, D., Martinez, Y., Ricke, D., Svensson, # R., Jackson, P. J.
(1999). Sequence and Organization of pXO1, the Large Bacillus anthracis Plasmid Harboring the Anthrax Toxin Genes. J. Bacteriol.
181: 6509-6515
[Abstract]
[Full Text]